SEHK:1246

Stock Analysis Report

Boill Healthcare Holdings

Executive Summary

Boill Healthcare Holdings Limited, an investment holding company, undertakes contracts for foundation piling in Hong Kong and Mainland China.


Snowflake Analysis

Fair value with mediocre balance sheet.

Share Price & News

How has Boill Healthcare Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 1246's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-3.8%

1246

0.6%

HK Construction

0.3%

HK Market


1 Year Return

-30.1%

1246

-26.0%

HK Construction

-5.1%

HK Market

Return vs Industry: 1246 underperformed the Hong Kong Construction industry which returned -26% over the past year.

Return vs Market: 1246 underperformed the Hong Kong Market which returned -5.1% over the past year.


Shareholder returns

1246IndustryMarket
7 Day-3.8%0.6%0.3%
30 Day-8.9%-5.2%-3.9%
90 Day-29.2%-1.7%4.4%
1 Year-30.1%-30.1%-22.5%-26.0%-1.6%-5.1%
3 Year-70.5%-70.5%-36.5%-43.3%13.4%1.9%
5 Year-88.3%-89.3%-23.9%-35.2%15.6%-3.6%

Price Volatility Vs. Market

How volatile is Boill Healthcare Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Boill Healthcare Holdings undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 1246 (HK$0.05) is trading below our estimate of fair value (HK$0.36)

Significantly Below Fair Value: 1246 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 1246 is unprofitable, so we can't compare its PE Ratio to the Construction industry average.

PE vs Market: 1246 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 1246's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 1246 is good value based on its PB Ratio (0.9x) compared to the HK Construction industry average (1x).


Next Steps

Future Growth

How is Boill Healthcare Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

10.9%

Forecasted Capital Goods industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Boill Healthcare Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Boill Healthcare Holdings performed over the past 5 years?

-25.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 1246 is currently unprofitable.

Growing Profit Margin: 1246 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 1246 is unprofitable, and losses have increased over the past 5 years at a rate of -25.3% per year.

Accelerating Growth: Unable to compare 1246's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1246 is unprofitable, making it difficult to compare its past year earnings growth to the Construction industry (-5.4%).


Return on Equity

High ROE: 1246 has a negative Return on Equity (-17.53%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is Boill Healthcare Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 1246's short term assets (HK$260.0M) do not cover its short term liabilities (HK$1.3B).

Long Term Liabilities: 1246's short term assets (HK$260.0M) exceed its long term liabilities (HK$10.6M).


Debt to Equity History and Analysis

Debt Level: 1246's debt to equity ratio (95.5%) is considered high.

Reducing Debt: 1246's debt to equity ratio has increased from 6.7% to 95.5% over the past 5 years.


Balance Sheet

Inventory Level: 1246 has a low level of unsold assets or inventory.

Debt Coverage by Assets: 1246's debt is not covered by short term assets (assets are 0.3x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable 1246 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: 1246 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 34.2% per year.


Next Steps

Dividend

What is Boill Healthcare Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 1246's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 1246's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 1246's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1246's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 1246's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.5yrs

Average board tenure


CEO

Boill Healthcare Holdings has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Dong Xing Dai
Chairman2.5yrsHK$1.70mno data
Sheng Hai Zhang
Executive Director2.5yrsHK$497.00kno data
Chi Keung Chan
Independent Non-Executive Director2.3yrsHK$120.00kno data
Kwong Kau Chui
Non-Executive Director4.9yrsHK$120.00kno data
Zhe Wang
Independent Non-Executive Director2.5yrsHK$120.00kno data
Liang Wei Xu
Independent Non-Executive Director2.5yrsHK$120.00kno data

2.5yrs

Average Tenure

54yo

Average Age

Experienced Board: 1246's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Boill Healthcare Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Boill Healthcare Holdings Limited
  • Ticker: 1246
  • Exchange: SEHK
  • Founded: 1983
  • Industry: Construction and Engineering
  • Sector: Capital Goods
  • Market Cap: HK$471.848m
  • Shares outstanding: 9.07b
  • Website: https://www.boillhealthcare.com.hk

Number of Employees


Location

  • Boill Healthcare Holdings Limited
  • Shun Tak Centre West Tower
  • Unit 3704, 37th Floor
  • Sheung Wan
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
1246SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDOct 2013

Biography

Boill Healthcare Holdings Limited, an investment holding company, undertakes contracts for foundation piling in Hong Kong and Mainland China. It operates through four segments: Foundation Piling, Property Development, Investment Securities, and Healthcare Holiday Resort Development and Operation. The company develops and sells properties, as well as provides property management services. In addition, it trades and invests in securities; and provides elderly home care, healthcare, and leisure services. The company was formerly known as Ngai Shun Holdings Limited and changed its name to Boill Healthcare Holdings Limited in September 2017. Boill Healthcare Holdings Limited was founded in 1983 and is based in Sheung Wan, Hong Kong. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/02/20 13:12
End of Day Share Price2020/02/20 00:00
Earnings2019/09/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.